Search

everythinglearnresearchcommunity

for

Search:↓

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

The study aims to find the best PRP dose for treating moderate carpal tunnel syndrome.

Baicalin may help treat severe drug-induced skin reactions.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The oral supplement improved hair loss in patients with telogen effluvium.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Kojyl cinnamate ester derivatives can promote hair growth by increasing adiponectin production in fat tissues.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Baricitinib shows promise in treating severe hair loss.

Phenylpropanoid sucrose esters show potential as anticancer agents.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Targeting ornithine decarboxylase can help prevent skin cancer.

Reducing gefitinib dosage improved hair loss, but scarring remained.